Home/Filings/4/0001415889-17-001505
4//SEC Filing

EISENBERG JEFFREY F 4

Accession 0001415889-17-001505

CIK 0001109196other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:20 PM ET

Size

5.8 KB

Accession

0001415889-17-001505

Insider Transaction Report

Form 4
Period: 2017-09-15
Transactions
  • Award

    Restricted Stock Unit

    2017-09-15+24,21024,210 total
    Common Stock (24,210 underlying)
Footnotes (1)
  • [F1]Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts.

Issuer

MABVAX THERAPEUTICS HOLDINGS, INC.

CIK 0001109196

Entity typeother

Related Parties

1
  • filerCIK 0001224096

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:20 PM ET
Size
5.8 KB